Bayer AG (MEX:BAYNN) Interest Expense (Positive)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:BAYNN Bayer AG MEX:BAYNN
39 GF Score
Price MXN912.16
GF Value MXN434.70
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bayer AG Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.

MEX:BAYNN
39GF Score
Bayer AG MEX:BAYNN
Interest Expense (Positive) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (MEX:BAYNN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of MXN912.16 is trading 109.8% above its estimated GF Value™ of MXN434.70. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for MEX:BAYNN:

  • Interest Expense (Positive):
  • GF Value™: MXN434.70 vs. price of MXN912.16 (109.8% above fair value)
  • GF Score™: 39/100 with 3 warning signs

No single metric tells the full story. See the MEX:BAYNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
39GF Score

Get the complete analysis for MEX:BAYNN

Interest Expense (Positive) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN912.16
Price
MXN434.70
GF Value